Department of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg; Cancer Registry Saarland, Saarbrücken; Institute for Medical Biometrics and Information Science, University of Heidelberg; Department of Preventive Oncology, German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT), Heidelberg; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg.
Dtsch Arztebl Int. 2017 Feb 10;114(6):87-93. doi: 10.3238/arztebl.2017.0087.
Participation rates in bowel cancer screening programs in Germany continue to be low. In a model project, a logistically simple procedure for inviting patients to participate was tested as a means of increasing participation.
A randomized trial was performed involving persons residing in the German federal state of Saarland who had either their 50th or their 55th birthday in the year beginning on 1 April 2012 (18 560 and 16 824 persons, respectively). The 50-year-olds received a written invitation to undergo a test for blood in the stool, either with or without a stool test attached, or else no invitation at all. The 55-year-olds received either an invitation to undergo colonoscopy or no invitation. Participation rates within one year were determined from billing data of the Saarland Association of Statutory Health. Insurance Physicians. The trial was registered in the German Registry of Clinical Trials, no. DRKS00006098.
A written invitation to undergo testing of the stool for blood, together with an accompanying test, increased the participation rate within one year by 62% (from 15% to 25%, p <0.001, especially among men (+158% vs. +39% for women). The participation rate was higher in general among women than among men (33% vs. 17%). On the other hand, a written invitation with no accompanying test did not increase the participation rate. A written invitation to undergo colonoscopic screening increased the participation rate within one year by 32% (5.9% vs 4.4%, p <0.001).
Targeted invitations can markedly increase participation rates in cancer screening. Written invitations to undergo stool testing for blood should be accompanied by an actual test. Further trials should also include information about the number of adenomas and carcinomas detected by screening.
德国的肠癌筛查计划参与率仍然很低。在一个模型项目中,测试了一种逻辑简单的邀请患者参与的程序,以提高参与率。
在一项涉及居住在德国萨尔州的人的随机试验中,这些人在 2012 年 4 月 1 日开始的那一年分别年满 50 岁或 55 岁(分别有 18560 人和 16824 人)。50 岁的人收到了一份书面邀请,要求他们进行粪便潜血检测,或者附有粪便检测,或者根本不邀请。55 岁的人收到了结肠镜检查的邀请或没有邀请。通过萨尔兰法定健康保险医师协会的计费数据确定一年内的参与率。该试验在德国临床试验注册处注册,编号为 DRKS00006098。
书面邀请进行粪便潜血检测,并附有配套检测,将一年内的参与率提高了 62%(从 15%提高到 25%,p<0.001,特别是男性(+158%比女性+39%)。女性的参与率普遍高于男性(33%比 17%)。另一方面,没有附带检测的书面邀请并没有提高参与率。书面邀请进行结肠镜筛查,将一年内的参与率提高了 32%(5.9%比 4.4%,p<0.001)。
有针对性的邀请可以显著提高癌症筛查的参与率。书面邀请进行粪便潜血检测应附有实际检测。进一步的试验还应包括通过筛查检测到的腺瘤和癌数量的信息。